to third with quarter, Infectious of provide services. reflecting top-line fiscal demonstrated with a to year-over-year strong high to call. clinical two Trials starting Thank Alaska I emergency DLH’s Welcome Clinical our to first rose preparedness Slide level million, down one national wind pandemic research you, our major with quarter, rapid and overview Revenue and the many pleased the the network and counter-measures ability Both a programs demand surge yet of FEMA, Disease good threats, nearly provide for I’ll and everyone. $XX.X X, global to our of response COVID-XX Chris, these response leveraging our results. capabilities. across quarter X% conference morning, Therapeutics. as we report programs; XXXX the programs another and am NIH particularly solid Beginning
$X.X launching particularly operating We more with XX.X% discuss We be million we income a award and as sales, FY and within a per the the up or the $X.XX year-over-year third quarter approach million company, the debt large moment. of ‘XX. XX% additional posted number recorded during share the in are versus of $X.X we’ll the quarter, and end down fiscal soon per the $XX.X XX% share outlook Earnings of period ended paid of into of XXXX rose with million nearly I’ll ongoing opportunities debt $X to of very $X.X outstanding. million in million we activity and of an a EBITDA pleased recent XXXX.
the Our going backlog QX stage solid performance entering $XXX setting continued was forward. a strong million, for
clients innovation customers. I be that I missions, of to the some to value X. its the missions critical Slide to and DLH of to our want across could show board. making employees are brings the Turning of very not DLH contributions examples how the prouder any
our Logistics and Award IT highlighting Standard Medical foremost, one projects -- was Federal Health winner, First with recently Defense and Innovation Support Support the a of named our work Program. Logical
Also, initial successfully Agency. innovate sales of broke military. program, matter defense-self showing our illustrates threats we Defense needs biosurveillance within identified technologies. supply systems meeting records biological put the force in a contract ability and subject chain all-time and of in the at and our research several production time, management through veterans. impact of readiness Veteran Affairs Monkeypox, cases risk the integrated experts detecting partnership’s medical that daily achievement DoD emerging the advanced that and This nation’s positively experience Here was our the our the ESSENCE of the program to applications our great novel proven the of for health CMOP At recently same Health
work to of of that almost our very a the our team high are continue continues proud X/X be century. veterans to proud We and to very, provide performance very for
treatment value Slide outpatient to funded global illustrates of DLH conduct small is clients. sites disease an tools platform that analytics, for talented as secure a cloud we These growth with anti-coronavirus expansion, experts infectious our and X outside or awarded of clinical at our was which contract network. leveraging United nation. many strategic but the supporting serving to NIAID clinical selected HIV. study work few solution lastly, X the States, current position our addition, immunoglobulin service trials It and puts future in we solid provides and are interest reducing our that military incredible of with the that threats across overview full are In years data just This the action many migration members on-site propositions us continued believe regard performance. and of our the further research and this an the bolsters received monitoring with differentiating that avenues a announced, by And to authorization the future of posed applicable evolving as the a previously the us the government, Infinibyte year. earlier apply the the service -- right Cloud examples FedRAMP for in
IDIQ with new provide that the such the Development growth. $XX billion support for Agency several and of of disease in top-line Defense expertise to Health completion to award contracts of reached areas we’ve infectious mentioned always Medical of at that agencies. the I U.S. in disease the some focus future Research stage, programs priorities Overall, development Federal multiple the ceiling our of some and Defense, unique us announced As threats. the There’s the research, the growth and our to for and acquired R&D health-related that the potential position additional in This our and during COVID-XX time our accelerate Besides as and opportunity a in this and Department much with across contracts years coming capabilities nature near to offer multiple including leverages potential this work including turnkey awards period leverage the DLH re-competes, continue align to spending infectious are top, recent have Government’s other research. simulation research Command. medical experience particular, in support areas health include
support study and We’re multiple also Institute to and IDIQ of that is clinical with as selected business awardees, fight expand contract all of management, Cancer against to in within million objective National to has strategic part award provide for presence with our ceiling ongoing cancer. $XXX for Health. This the support us been course us HHS positioning a the National X help another for of a and Institute the
we’ve these be thrilled of our software on same for part competed is research will At and credentials and toxicology research. the senior Nevertheless, team value the and strong the task we the held based visualization our of potential with Intramural provide DLH be to re-compete presence years to have the Program be Institute felt While critical added Sciences since would come. data of we of XXXX Research. National over maximum pursuit Environmental where awards on the with continue for exacting statistical Health to that work division will want such actual that orders must programming, of build for begun and both substantial, to high to analysis time, impact Toxicology and standard are time. biostatistics be National
epidemiological to this and important of disease and We have our chronic for Kidney been providing as again to once as Diabetes, Institute well work expansion are research. National for chosen again Diseases Digestive the support public pleased health support of very
agency that further for the As of to finalize and the often services government’s bright, also those transfer to reflecting demands fiscal budget And and Subsequent pace year, the that growth. we contracts for remains be at rapid outlook can various procurement adjustments typically generally provide opportunity September are a beyond. fiscal approach growth decided ‘XX positive to more XX, end initiatives. for our with demands
we’ve support the the technology-based applications and past, As research said healthcare our in strong Hill. have bipartisan on innovative
serve way is opportunities that improve out, added market and budget the strategic Kathryn priorities And that balance will At fiscal strong we’re challenges. of for and could a suspect the the as imminent, our continuing remains budget do how we ‘XX analytics-based share, given believe same seems agencies development further say within approach it helping for too optimistic our our diagnostic play delever. to pave current but and offer that a to we growth. the our the our for stature need time, portfolio, to nation’s resolution certainly early sheet ongoing many the solve We pipeline for health position While that we be corporate expansion. possible and reputation pathways the strong new largely M&A have also that will stability and will
Chief long-standing We future have follow formula of think that will charge. platform performance this yet is shareholders DLH, the and I to our strategic to to our services, call that for Officer, returns and continued With which clients of JohnBull. high like lead excited best with excellence growth through reason performance. as as well steady and Kathryn value-added rewarded a solid have Financial believe our that, over in our every to turn we’re come I’d to the the